Low-level environmental tobacco smoke exposure and inflammatory biomarkers in children with asthma

References

• Schwartz J, Timonen KL, Pekkanen J. Respiratory effects of environmental tobacco smoke in a panel study of asthmatic children and symptomatic children. Am J Respir Crit Care Med 2000;161:802–806
   PubMed Web of Science ®Google Scholar
• Mannino DM, Homa DM, Redd SC. Involuntary smoking and asthma severity in children: data from the third national health and nutrition examination survey. Chest 2002;122:409–415
   PubMed Web of Science ®Google Scholar
• Comhair SAA, Gaston BM, Ricci KS, Hammel J, Dweik RA, Teaque WG, Ampleford EJ, et al. Detrimental effects of environmental tobacco smoke in relation to asthma severity. PLoS One 2011;6:e18574
   PubMed Web of Science ®Google Scholar
• Chalmers GW, MacLeod KJ, Little SA, Thompson LJ, McSharry CP, Thomson NC. Influence of cigarette smoking on inhaled corticosteroid treatment in mild asthma. Thorax 2002;57:226–230
   PubMed Web of Science ®Google Scholar
• Lazarus SC, Chinchilli VM, Rollings NJ, Boushey HA, Cherniack R, Craig TJ, Deykin A, et al. Smoking affects response to inhaled corticosteroids or leukotriene receptor antagonists in asthma. Am J Respir Crit Care Med 2007;175:783–790
   PubMed Web of Science ®Google Scholar
• Chaudhuri R, Livingston E, McMahon AD, Thomson L, Borland W, Thomson NC. Cigarette smoking impairs therapeutic response to oral corticosteroids in chronic asthma. Am J Respir Crit Care Med 2003;168:1308–1311
   PubMed Web of Science ®Google Scholar
• Winickoff JP, Friebely J, Tanski SE, Sherrod C, Matt GE, Hovell MF, McMillen RC. Beliefs about the health effects of “thirdhand” smoke and home smoking bans. Pediatrics 2009;123:e74–e79
   PubMed Web of Science ®Google Scholar
• Johansson AK, Heermansson G, Ludvigsson J. How should parents protect their children from environmental tobacco-smoke exposure in the Home? Pediatrics 2004;113:e291–e295
   PubMed Web of Science ®Google Scholar
• Becquemin MH, Bertholon JF, Bentayeb M, Attoui M, Ledur D, Roy F, Roy M, et al. Third-hand smoking: indoor measurements of concentration and sizes of cigarette smoke particles after resuspension. Tob Control 2010;19:347–348
   PubMed Web of Science ®Google Scholar
• Matt GE, Quintana PJ, Destaillats H, Gundel LA, Sleiman M, Singer BC, Jacob P, et al. Thirdhand tobacco smoke: emerging evidence and arguments for a multidisciplinary research agenda. Environ Health Perspect 2011;119:1218–1226
   PubMed Web of Science ®Google Scholar
• Butz AM, Breysse P, Rand C, Curtin-Brosnan J, Eggleston P, Diette GB, Williams D, et al. Household smoking behavior: effects on indoor air quality and health of urban children with asthma. Matern Child Health J 2011;15:460–468
   PubMed Web of Science ®Google Scholar
• Matt GE, Quintana PJE, Zakarian JM, Fortmann AL, Chatfield DA, Hoh E, Uribe AM, et al. When smokers move out and non-smokers move in: residential thirdhand smoke pollution and exposure. Tob Control 2011;20:e1–e8
   PubMed Web of Science ®Google Scholar
• Matt GE, Quintana P, Hovell N, Bernert JT, Song S, Novianti N, Juarez T, et al. Households contaminated by environmental tobacco smoke: sources of infant exposures. Tob Control 2004;13:29–37
   PubMed Web of Science ®Google Scholar
• Kharitonov SA, Barnes PJ. Exhaled markers of pulmonary disease (State of the Art Review). Am J Respir Crit Care Med 2001;163:1692–1722
   Web of Science ®Google Scholar
• Petsky HL, Cates CJ, Li A, Kynaston JA, Turner C, Chang AB. Tailored interventions based on exhaled nitric oxide versus clinical symptoms for asthma in children and adults. Cochrane Database Syst Rev 2009;(4):CD006340
   PubMed Web of Science ®Google Scholar
• Rabinovitch N. Urinary leukotriene E4. Immunol Allergy Clin North Am 2007;27:651–664
   PubMed Web of Science ®Google Scholar
• Wadsworth S, Sin D, Dorscheid D. Clinical update on the use of biomarkers of airway inflammation in the management of asthma. J Asthma Allergy 2011;4:77–86
   PubMedGoogle Scholar
• Dweik RA, Boggs PB, Erzurum SC, Irvin CG, Leigh MW, Lundberg JO, Olin AC, et al. An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical applications. Am J Respir Crit Care Med 2011;184:602–615
   PubMed Web of Science ®Google Scholar
• Strunk RC, Szefler SJ, Phillips BR, Zeiger RS, Chinchilli VM, Larsen G, Hodgdon K, et al. Relationship of exhaled nitric oxide to clinical and inflammatory markers of persistent asthma in children. J Allergy Clin Immunol 2003;112:883–892
   PubMed Web of Science ®Google Scholar
• Baraldi E, Azzolin NM, Zanconato S, Dario C, Zacchello F. Corticosteroids decrease exhaled nitric oxide in children with acute asthma. J Pediatr 1997;131:381–385
   PubMed Web of Science ®Google Scholar
• Knuffman JE, Sorkness CA, Lemankse RF Jr, Mauger DT, Boehmer SJ, Martinez FD, Bacharier LB, et al. Phenotypic predictors of long-term response to inhaled corticosteroid and leukotriene modifier therapies in pediatric asthma. J Allergy Clin Immunol 2009;123:411–416
   PubMed Web of Science ®Google Scholar
• Kharitonov SA, Barnes PJ. Clinical aspects of exhaled nitric oxide. Eur Respir J 2000;16:781–792
   PubMed Web of Science ®Google Scholar
• Dweik RA. The promise and reality of nitric oxide in the diagnosis and treatment of lung disease. Cleve Clin J Med 2001;68:486,488,490,493
   PubMed Web of Science ®Google Scholar
• Nadif R, Matran R, Maccario J, Bechet M, Le Moual N, Scheinmann P, Bousquet J, Kauffmann F, et al. Passive and active smoking and exhaled nitric oxide levels according to asthma and atopy in adults. Ann Allergy Asthma Immunol 2010;104:385–393
   PubMed Web of Science ®Google Scholar
• Dinakar C, Lapuente M, Barnes C, Garg U. Real-time environmental tobacco smoke exposure does not affect exhaled nitric oxide levels in asthmatic children. J Asthma 2005;42:113–118
   PubMed Web of Science ®Google Scholar
• de la Riva-Velasco E, Krishnan S, Dozor AJ. Relationship between exhaled nitric oxide and exposure to low-level environmental tobacco smoke in children with asthma on inhaled corticosteroids. J Asthma 2012;49:673–678
   PubMed Web of Science ®Google Scholar
• Montuschi P, Mondino C, Koch P, Barnes PJ, Ciabattoni G. Effects of a leukotriene receptor antagonist on exhaled leukotriene E4 and prostanoids in children with asthma. J Allergy Clin Immunol 2006;118:347–353
   PubMed Web of Science ®Google Scholar
• Rabinovitch N, Zhang L, Gelfand EW. Urine leukotriene E4 levels are associated with decreased pulmonary function in children with persistent airway obstruction. J Allergy Clin Immunol 2006;118:635–640
   PubMed Web of Science ®Google Scholar
• Zeiger RS, Szefler SJ, Phillips BR, Schatz M, Martinez FD, Chinchilli VM, Lemanske RF Jr, et al. Response profiles to fluticasone and montelukast in mild-to-moderate persistent childhood asthma. J Allergy Clin Immunol 2006;117:45–52
   PubMed Web of Science ®Google Scholar
• Cai C, Yang J, Hu S, Zhou M, Guo W. Relationship between urinary cysteinyl leukotriene E4 levels and clinical response to antileukotriene treatment in patients with asthma. Lung 2007;185:105–112
   PubMed Web of Science ®Google Scholar
• Karaman O, Sünneli L, Uzuner N, Islekel H, Turgut CS, Kose S, Tezcan D, et al. Evaluation of montelukast in 8 to 14 year old children with mild persistent asthma and compared with inhaled corticosteroids. Allergol Immunopathol 2004;32:21–27
   PubMedGoogle Scholar
• Kott KS, Salt BH, McDonald RJ, Jhawar S, Bric JM, Joad JP. Effect of secondhand cigarette smoke, RSV bronchiolitis and parental asthma on urinary cysteinyl LTE4. Pediatr Pulmonol 2008;43:760–766
   PubMed Web of Science ®Google Scholar
• Gaki E, Papatheodorou G, Ischaki E, Grammenou V, Papa I, Loukides S. Leukotriene E4 in urine in patients with asthma and COPD: the effect of smoking habit. Respir Med 2007;101:826–832
   PubMed Web of Science ®Google Scholar
• Fauler J, Frolich JC. Cigarette smoking stimulates cysteinyl leukotriene production in man. Eur J Clin Invest 1997;27:43–47
   PubMed Web of Science ®Google Scholar
• Rabinovitch N, Strand M, Stuhlman K, Gelfand EW. Exposure to tobacco smoke increases leukotriene E4-related albuterol usage and response to montelukast. J Allergy Clin Immunol 2008;121:1365–1371
   PubMed Web of Science ®Google Scholar
• Rabinovitch N, Graber NJ, Chinchilli VM, Sorkness CA, Zeiger RS, Strunk RC, Bacharier LB, et al. Urinary leukotriene E4/exhaled nitric oxide ratio and montelukast response in childhood asthma. J Allergy Clin Immunol 2010;126:545–551
   PubMed Web of Science ®Google Scholar
• Benowitz N. Biomarkers of environmental tobacco smoke exposure. Environ Health Perspect 1999;107:349–355
   PubMed Web of Science ®Google Scholar
• Benowitz NL. Cotinine as a biomarker of environmental tobacco smoke exposure. Epidemiol Rev 1996;18:188–202
   PubMed Web of Science ®Google Scholar
• National Heart, Lung, and Blood Institute. Expert Panel 3 (EPR3): Guidelines for the Diagnosis and Management of Asthma. NIH/NHLBI. Full Report 2007 . Available from: www.nhlbi.nih.gov/guidelines/asthma/asthgdln.htm
   Google Scholar
• Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Crapo R, et al. ATS/ERS Task Force. Standardisation of spirometry. Eur Respir J 2005;26:319–338
   PubMed Web of Science ®Google Scholar
• Hankinson JL, Odencrantz JR, Fedan KB. Spirometric reference values from a sample of the general US population. Am J Respir Crit Care Med 1999;159:179–187
   PubMed Web of Science ®Google Scholar
• Nathan RA, Sorkness CA, Kosinski M, Schatz M, Li JT, Marcus P, Murray JJ, et al. Development of the Asthma Control Test: a survey for assessing asthma control. J Allergy Clin Immunol 2004;113:59–65
   PubMed Web of Science ®Google Scholar
• Liu AH, Zeiger R, Sorkness C, Mahr T, Ostrom N, Burgess S, Rosenzweig JC, et al. Development and cross-sectional validation of the Childhood Asthma Control Test. J Allergy Clin Immunol 2007;119:817–825
   PubMed Web of Science ®Google Scholar
• Gehring U, Leaderer BP, Heinrich J, Oldenwening M, Giovannangelo ME, Nordling E, Merkel G, et al. Comparison of parental reports of smoking and residential air nicotine concentrations in children. Occup Environ Med 2006;63:766–772
   PubMed Web of Science ®Google Scholar
• Matt G, Hovell MF, Quintana PJE, Zakarian J, Liles S, Meltzer SB, Benowitz NL. The variability of urinary cotinine levels in young children: implications for measuring ETS exposure. Nicotine and Tob Res 2007;9:83–92
   PubMed Web of Science ®Google Scholar
• Oddoze C, Dubus JC, Badier M, Thirion X, Pauli AM, Pastor J, Bruguerolle B. Urinary cotinine and exposure to parental smoking in a population of children with asthma. Clin Chem 1999;45:505–509
   PubMed Web of Science ®Google Scholar
• ATS/ERS. recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide. Am J Respir Crit Care Med 2005;171:912–930
   PubMed Web of Science ®Google Scholar
• Dal Negro RW, Visconti M, Micheletto C, Tognella S, Guerriero M. Reference urinary LTE4 levels in normal individuals: a pilot study. Eur Ann Allergy Clin Immunol 2011;43:22–28
   PubMedGoogle Scholar
• Rabinovitch N, Reisdorph N, Silveira L, Gelfand EW. Urinary leukotriene E4 levels identify children with tobacco smoke exposure at risk for asthma exacerbation. J Allergy Clin Immunol 2011;128:323–327
   PubMed Web of Science ®Google Scholar
• Sorkness CA, Lemanske RF Jr, Mauger DT, Boehmer SJ, Chinchilli VM, Martinez FD, Strunk RC, et al. Long-term comparison of 3 controller regimens for mild-moderate persistent childhood asthma: the Pediatric Asthma Controller Trial. J Allergy Clin Immunol 2007;119:64–72
   PubMed Web of Science ®Google Scholar
• Fritscher LG, Rodrigues MT, Zamel N, Chapman KR. The effect of montelukast on exhaled nitric oxide of alveolar and bronchial origin in inhaled cortico-steroid treated asthma. Respir Med 2009;103:296–300
   PubMed Web of Science ®Google Scholar